Influence of Surface Ligand Density and Particle Size on the Penetration of the Blood–Brain Barrier by Porous Silicon Nanoparticles
Влияние плотности поверхностных лигандов и размера частиц на проникновение пористых кремниевых наночастиц через гематоэнцефалический барьер
2023-09-03
SCID: 54.1/yxds3qpz
Discuss with AI
BBB-on-a-chip modelblood–brain barrierparticle sizeporous silicon nanoparticlestransferrin surface density
Figures from the paper
Abstract (AI)
Overcoming the blood-brain barrier (BBB) remains a significant challenge with regard to drug delivery to the brain. By incorporating targeting ligands, and by carefully adjusting particle sizes, nanocarriers can be customized to improve drug delivery. Among these targeting ligands, transferrin stands out due to the high expression level of its receptor (i.e., transferrin receptor) on the BBB. Porous silicon nanoparticles (pSiNPs) are a promising drug nanocarrier to the brain due to their biodegradability, biocompatibility, and exceptional drug-loading capacity. However, an in-depth understanding of the optimal nanoparticle size and transferrin surface density, in order to maximize BBB penetration, is still lacking. To address this gap, a diverse library of pSiNPs was synthesized using bifunctional poly(ethylene glycol) linkers with methoxy or/and carboxyl terminal groups. These variations allowed us to explore different transferrin surface densities in addition to particle sizes. The effects of these parameters on the cellular association, uptake, and transcytosis in immortalized human brain microvascular endothelial cells (hCMEC/D3) were investigated using multiple in vitro systems of increasing degrees of complexity. These systems included the following: a 2D cell culture, a static Transwell model, and a dynamic BBB-on-a-chip model. Our results revealed the significant impact of both the ligand surface density and size of pSiNPs on their ability to penetrate the BBB, wherein intermediate-level transferrin densities and smaller pSiNPs exhibited the highest BBB transportation efficiency in vitro. Moreover, notable discrepancies emerged between the tested in vitro assays, further emphasizing the necessity of using more physiologically relevant assays, such as a microfluidic BBB-on-a-chip model, for nanocarrier testing and evaluation.
Key Findings
1
A library of porous silicon nanoparticles was engineered with varied particle sizes and transferrin ligand surface densities using bifunctional PEG linkers.
2
Both transferrin surface density and nanoparticle size significantly influenced cellular association, uptake, and BBB transcytosis in vitro.
3
Intermediate transferrin densities and smaller porous silicon nanoparticles showed the highest blood–brain barrier transport efficiency across the tested systems.
4
Results differed substantially among 2D cultures, static Transwell assays, and dynamic BBB-on-a-chip models.
5
The findings support using physiologically relevant microfluidic BBB-on-a-chip assays to evaluate nanocarrier penetration more reliably.
Research Object
Transferrin-functionalized porous silicon nanoparticles (pSiNPs) of varying particle sizes and surface ligand densities interacting with in vitro blood–brain barrier models
Research Subject
The effects of pSiNP particle size and transferrin surface density on cellular association, uptake, transcytosis, and blood–brain barrier penetration efficiency
Publication Details
Publication Date
2023-09-03
Journal
Publisher
ISSN
Cited by
32
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases2018
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges2019
In Situ Surface Modification of Microfluidic Blood–Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles2020